SCHEMBL7401301

SCHEMBL7401301

O=C(O)CNC(=O)OCc1ccccn1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.67
RAB9A P51151 5/20 0.67
SMN1; SMN2 Q16637 5/20 0.67
LMNA P02545 1/20 0.67
MAPT P10636 1/20 0.53
HDAC1 Q13547 2/20 0.52
KCNA5 P22460 2/20 0.47
KCNK3 O14649 1/20 0.47
KCNA3 P22001 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC2 Q92769 1/20 0.46
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
POLB P06746 1/20 0.46
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
KMT2A Q03164 1/20 0.44
PARP10 Q53GL7 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7345056 0.85 SMN1; SMN2 (0.59) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL6841168 0.83 NPC1 (0.64) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL27791622 0.81 POLB (0.62) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL8211405 0.80 NPC1 (1.00) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL16078292 0.80 SMN1; SMN2 (0.68) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL13564630 0.80 NPC1 (0.68) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL8405764 0.79 NPC1 (0.59) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL11377704 0.79 SMN1; SMN2 (0.66) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL23585702 0.78 SMN1; SMN2 (0.58) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL14030744 0.78 POLB (0.63) NPC1RAB9ASMN1; SMN2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed